Toronto Dominion Bank Arvinas, Inc. Transaction History

Toronto Dominion Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$36.01 - $74.24 $262,873 - $541,952	-7,300 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$60.27 - $81.57 $90,405 - $122,354	-1,500 Reduced 17.05%	7,300 $491,000
Q4 2021 Feb 04, 2022	BUY	$65.85 - $96.21 $579,480 - $846,648	8,800 New	8,800 $723,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.